Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2-Reference-Cited by-同舟云学术

Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2

Published:2022-02 Issue:5 Volume:38 Page:110319
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Yan Rong,Zhu Hongyan,Huang Piao,Yang Min,Shen Mengzhen,Pan Yuting,Zhang Chengqian,Zhou Xianglian,Li Huiliang,Ke Xisong,Zhang Weidong,Hao Piliang,Qu Yi

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference36 articles.

1. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death;Borghi;Biochem. Pharmacol.,2016

2. Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation;Chan;Proc. Natl. Acad. Sci. U S A,2002

3. Wnt/beta-catenin signaling in development and disease;Clevers;Cell,2006

4. Is β-catenin a druggable target for cancer therapy?;Cui;Trends Biochem. Sci.,2018

5. Oleanane triterpenoids with inhibitory activity against NFAT transcription factor from liquidambar formosana;Dat;Biol. Pharm. Bull.,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diterpene glycosides from Fructus Rubi ameliorates benign prostatic hyperplasia in rats through the androgen and TGF-β/Smad signaling pathway;Journal of Ethnopharmacology;2025-01

2. Structural analysis of Salvia miltiorrhiza polysaccharide and its regulatory functions on T cells subsets in tumor-bearing mice combined with thymopentin;International Journal of Biological Macromolecules;2024-10

3. Liquidambaric acid inhibits the proliferation of hepatocellular carcinoma cells by targeting PPARα-RXRα to down-regulate fatty acid metabolism;Toxicology and Applied Pharmacology;2024-09

4. Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (optineurin)-dependent Mitophagy;Autophagy;2024-08-04

5. Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential;Heliyon;2024-08